Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia

NCT00020670 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Leukemia

Interventions

BIOLOGICAL: CD 40

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]